ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Combining Magnetic Resonance Diffusion-Weighted Imaging with Prostate-Specific Antigen to Differentiate Between Malignant and Benign Prostate Lesions

Han, Liying; He, Guanyong; Mei, Yingjie; Yu, Qing; Zhao, Minning; Luo, Fu; Cheng, Guanxun*; Liang, Wen*北京大学; 南方医科大学
MEDICAL SCIENCE MONITOR2022-4-23DOI: 10.12659/MSM.935307
2被引8阅读
引用收藏
分享

摘要

Background: We aimed to develop a combined model of quantitative parameters derived from 3 different magnetic resonance imaging (MRI) diffusion models and laboratory data related to prostate-specific antigen (PSA) for differentiating between prostate cancer (PCa) and benign lesions. Material/Methods: Eighty-four patients pathologically confirmed as having PCa or benign disease were enrolled. All patients underwent multiparametric MRI before biopsy, added intravoxel incoherent motion (IVIM) imaging, and diffusion kurtosis imaging (DKI). The following data were collected: quantitative parameters of diffusion-weighted imaging (DWI), IVIM, and DKI, preoperative total PSA, free/total PSA ratio, and PSA density (PSAD) values. A combined logistic regression model was established by above MRI quantitative parameters and PSA data to diagnose PCa. The Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) was used to assess the lesions for comparison. Results: Thirty-two patients had PCa and 52 patients had benign lesions. In multivariate logistic regression analysis, only apparent diffusion coefficient (ADC) and PSAD were significant variables (P<0.05) and were thus retained in the model. The area under curve value of the combined model (0.911) was higher than that of ADC, PSAD, and PI-RADS v2 (0.887, 0.861, and 0.859, respectively) in univariate analysis, but without any statistically significant differences. The combined model generated greater clinical benefit than the independent application of ADC, PSAD, and PI-RADS v2. Conclusions: ADC and PSAD were the 2 most important metrics for distinguishing PCa from benign lesions. The combined model of ADC and PSAD demonstrated satisfactory discrimination and improved clinical net benefit.

学科与关键词

关键词
Diffusion Magnetic Resonance ImagingLogistic ModelsProstate CancerFamilialProstate-Specific Antigen
相关
加载中…
  • Diagnostic value and relative weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers
    Rouviere, Olivier; Dagonneau, Tristan; Cros, Fanny; Bratan, Flavie; Roche, Laurent; Mege-Lechevallier, Florence; Ruffion, Alain; Crouzet, Sebastien; Colombel, Marc; Rabilloud, MurielPLoS One, 2017, 12(6): e0178901.被引 5
  • Multimodal approach to optimize biopsy decision-making for PI-RADS 3 lesions on multiparametric MRI
    Esengur, Omer Tarik; Yilmaz, Enis C.; Ozyoruk, Kutsev B.; Chen, Alex; Lay, Nathan S.; Gelikman, David G.; Merino, Maria J.; Gurram, Sandeep; Wood, Bradford J.; Choyke, Peter L.; Harmon, Stephanie A.; Pinto, Peter A.; Turkbey, Baris*CLINICAL IMAGING, 2025, 117: 110363.
  • MRI combined with PSA density in detecting clinically significant prostate cancer in patients with PSA serum levels of 4~10 ng/mL: Biparametric versus multiparametric MRI
    Han, C.; Liu, S.; Qin, X. B.; Ma, S.; Zhu, L. N.; Wang, X. Y.*Diagnostic and Interventional Imaging, 2020, 101(4): 235-244.被引 40
查看全部 →

发表信息

论文状态
公开发表
期刊
MEDICAL SCIENCE MONITOR
发表日期
2022-04-23
卷期
第 28 卷
页码
e935307
DOI
10.12659/MSM.935307
成果收录
SCIE
资助标注
Project to Improving Discipline Construction Capacity of Shenzhen Health and Family Planning System [SZXJ2018076]

作者

  • H

    Han, Liying (第一作者)

    peking univ shenzhen

  • H

    He, Guanyong

    peking univ shenzhen

查看全部 8 位作者收起作者
  • M

    Mei, Yingjie

    southern med univ

  • Y

    Yu, Qing

    southern med univ

  • Z

    Zhao, Minning

    southern med univ

  • L

    Luo, Fu

    southern med univ

  • C

    Cheng, Guanxun (通讯)

    peking univ shenzhen

  • L

    Liang, Wen (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417